Over the past 12 months, 4 insiders at Evolus, Inc. filed 8 open-market SEC Form 4 transactions on EOLS: 1 purchase worth $205K and 7 sales worth $932K. Insiders have been net sellers over this period. The most recent filing was on Mar 20, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 26 | Rui AvelarSee Remarks | SELL | 3.1K | $4.75 | $15K |
| Mar 20, 26 | David MoatazediSee Remarks | SELL | 13.7K | $4.75 | $65K |
| Mar 17, 26 | Rui AvelarSee Remarks | SELL | 30.0K | $4.89 | $147K |
| Mar 17, 26 | David MoatazediSee Remarks | SELL | 116.7K | $4.89 | $571K |
| Dec 22, 25 | Rui AvelarSee Remarks | SELL | 2.3K | $7.15 | $16K |
| Dec 22, 25 | David MoatazediSee Remarks | SELL | 10.5K | $7.15 | $75K |
| Aug 22, 25 | Tomoko Yamagishi-dresslerChief Marketing Officer | SELL | 5.7K | $7.51 | $43K |
| Aug 15, 25 | Brady StewartDirector | BUY | 30.0K | $6.82 | $205K |
| Jun 16, 25 | David MoatazediSee Remarks | SELL | 16.6K | $9.89 | $164K |
| Jun 13, 25 | David MoatazediSee Remarks | SELL | 111.3K | $10.05 | $1.1M |
| Jun 9, 25 | Albert G White IIIDirector | BUY | 20.0K | $9.45 | $189K |
| May 13, 25 | Sandra BeaverChief Financial Officer | SELL | 6.5K | $10.02 | $65K |
| May 12, 25 | Rui AvelarSee Remarks | SELL | 3.4K | $9.87 | $33K |
| May 12, 25 | David MoatazediSee Remarks | SELL | 15.8K | $9.87 | $156K |
| Mar 27, 25 | David MoatazediSee Remarks | SELL | 6.3K | $12.40 | $78K |
| Mar 18, 25 | Rui AvelarSee Remarks | SELL | 27.9K | $13.26 | $370K |
| Mar 18, 25 | Sandra BeaverChief Financial Officer | SELL | 9.0K | $13.26 | $119K |
| Mar 18, 25 | David MoatazediSee Remarks | SELL | 103.4K | $13.26 | $1.4M |
| Mar 18, 25 | Tomoko Yamagishi-dresslerChief Marketing Officer | SELL | 4.5K | $13.26 | $60K |
| Mar 12, 25 | Karah Herdman ParschauerDirector | SELL | 12.9K | $12.99 | $167K |
| Dec 23, 24 | Rui AvelarSee Remarks | SELL | 2.3K | $10.85 | $24K |
| Dec 23, 24 | Sandra BeaverChief Financial Officer | SELL | 1.6K | $10.85 | $17K |
| Dec 23, 24 | David MoatazediSee Remarks | SELL | 10.5K | $10.85 | $114K |
| Sep 6, 24 | Sandra BeaverChief Financial Officer | SELL | 3.3K | $14.98 | $49K |
| Aug 30, 24 | Tomoko Yamagishi-dresslerChief Marketing Officer | SELL | 5.6K | $15.85 | $89K |
| Jun 6, 24 | David MoatazediSee Remarks | SELL | 175.9K | $12.59 | $2.2M |
| Jun 5, 24 | David MoatazediSee Remarks | SELL | 155.3K | $12.92 | $2.0M |
| Jun 4, 24 | David MoatazediSee Remarks | SELL | 140.2K | $12.73 | $1.8M |
| Jun 3, 24 | Vikram MalikDirector | SELL | 7.5K | $12.96 | $97K |
| May 14, 24 | David N GillDirector | SELL | 6.7K | $12.60 | $85K |
| May 13, 24 | David N GillDirector | SELL | 3.6K | $12.72 | $46K |
| May 13, 24 | Vikram MalikDirector | SELL | 28.0K | $12.93 | $362K |
| May 10, 24 | Rui AvelarSee Remarks | SELL | 3.4K | $12.72 | $44K |
| May 10, 24 | Sandra BeaverChief Financial Officer | SELL | 2.4K | $12.72 | $31K |
| May 10, 24 | David MoatazediSee Remarks | SELL | 16.1K | $12.72 | $204K |
| Mar 27, 24 | David MoatazediSee Remarks | SELL | 6.2K | $13.86 | $86K |
| Mar 19, 24 | Rui AvelarSee Remarks | SELL | 27.6K | $13.92 | $384K |
| Mar 19, 24 | Sandra BeaverChief Financial Officer | SELL | 5.7K | $13.92 | $79K |
| Mar 19, 24 | David MoatazediSee Remarks | SELL | 96.6K | $13.92 | $1.3M |
| Feb 22, 24 | Rui AvelarSee Remarks | SELL | 1.8K | $13.08 | $24K |
| Feb 22, 24 | Sandra BeaverChief Financial Officer | SELL | 1.8K | $13.08 | $24K |
| Feb 22, 24 | David MoatazediSee Remarks | SELL | 7.7K | $13.08 | $101K |
| Jan 30, 24 | Karah Herdman ParschauerDirector | SELL | 11.9K | $13.14 | $157K |
| Dec 8, 23 | David MoatazediSee Remarks | SELL | 31.3K | $9.73 | $305K |
| Dec 6, 23 | David MoatazediSee Remarks | SELL | 51.3K | $10.09 | $518K |
| Oct 16, 23 | Medytox Inc.Other | SELL | 1.69M | $7.50 | $12.7M |
| Sep 6, 23 | Sandra BeaverChief Financial Officer | SELL | 3.2K | $9.70 | $31K |
| Aug 16, 23 | Rui AvelarSee Remarks | SELL | 2.2K | $10.27 | $23K |
| Aug 16, 23 | Sandra BeaverChief Financial Officer | SELL | 2.2K | $10.27 | $23K |
| Aug 16, 23 | David MoatazediSee Remarks | SELL | 14.8K | $10.27 | $152K |
Over the past 12 months, insiders at Evolus, Inc. filed 1 open-market purchase worth $205K and 7 sales worth $932K on EOLS, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 20, 26.
The largest recent open-market EOLS insider purchase in our data was $205K by Brady Stewart, Director, filed on Aug 15, 25.
4 different insiders at Evolus, Inc. filed open-market SEC Form 4 transactions on EOLS over the last 12 months.
InsiderTape plots every EOLS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Evolus, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →